242 related articles for article (PubMed ID: 23178576)
21. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID.
Wilbanks GA; Mammolenti M; Streilein JW
J Immunol; 1991 May; 146(9):3018-24. PubMed ID: 2016537
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
Yamada J; Zhu SN; Streilein JW; Dana MR
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
[TBL] [Abstract][Full Text] [Related]
23. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
Ishioka M; Okamoto S; Streilein JW; Jiang LQ
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
[TBL] [Abstract][Full Text] [Related]
24. Th1/Th2-balance in anterior chamber-associated immune deviation by alloantigen.
Sakai R; Yamagami S; Inoki T; Tsuru T; Kawashima H
Graefes Arch Clin Exp Ophthalmol; 2002 Feb; 240(2):154-9. PubMed ID: 11931082
[TBL] [Abstract][Full Text] [Related]
25. Anterior chamber associated immune deviation induced by TNP-splenocytes (TNP-ACAID). I. Systemic tolerance mediated by suppressor T-cells.
Waldrep JC; Kaplan HJ
Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1086-92. PubMed ID: 6192107
[TBL] [Abstract][Full Text] [Related]
26. The immune response and the eye: a role for TNF alpha in anterior chamber-associated immune deviation.
Ferguson TA; Herndon JM; Dube P
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2643-51. PubMed ID: 8163352
[TBL] [Abstract][Full Text] [Related]
27. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation.
Li XY; D'Orazio LT; Niederkorn JY
Immunology; 1996 Sep; 89(1):34-40. PubMed ID: 8911137
[TBL] [Abstract][Full Text] [Related]
28. Expansion of B cells is necessary for the induction of T-cell tolerance elicited through the anterior chamber of the eye.
Ashour HM; Niederkorn JY
Int Arch Allergy Immunol; 2007; 144(4):343-6. PubMed ID: 17671393
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of CD94 on CD8+T cells in anterior chamber-associated immune deviation.
He H; Yang P; Jiang L; Zhang J; Zhao C; Chen L; Lin X; Zhou H; Kijlstra A
BMC Immunol; 2008 Sep; 9():53. PubMed ID: 18816417
[TBL] [Abstract][Full Text] [Related]
30. The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen.
Ferguson TA; Herndon JM
Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):3085-93. PubMed ID: 8206727
[TBL] [Abstract][Full Text] [Related]
31. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.
Wilbanks GA; Streilein JW
J Immunol; 1991 Apr; 146(8):2610-7. PubMed ID: 1707912
[TBL] [Abstract][Full Text] [Related]
32. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye.
Hara Y; Caspi RR; Wiggert B; Dorf M; Streilein JW
J Immunol; 1992 Sep; 149(5):1531-8. PubMed ID: 1387141
[TBL] [Abstract][Full Text] [Related]
33. The in vivo and in vitro induction of anterior chamber associated immune deviation to myelin antigens in C57BL/6 mice.
Farooq SM; Elkhatib WF; Ashour HM
Brain Behav Immun; 2014 Nov; 42():118-22. PubMed ID: 24953428
[TBL] [Abstract][Full Text] [Related]
34. Analysis of immune deviation elicited by antigens injected into the subretinal space.
Wenkel H; Streilein JW
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1823-34. PubMed ID: 9727405
[TBL] [Abstract][Full Text] [Related]
35. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
36. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
[TBL] [Abstract][Full Text] [Related]
37. Indoleamine 2,3-dioxygenase (IDO) is involved in promoting the development of anterior chamber-associated immune deviation.
Chen X; Liu L; Yang P; Wu C; Jin H; Xing L; Li B; Zhou H; Huang X; Zhu L
Immunol Lett; 2006 Nov; 107(2):140-7. PubMed ID: 17055065
[TBL] [Abstract][Full Text] [Related]
38. Thymocytes induced by antigen injection into the anterior chamber activate splenic CD8+ suppressor cells and enhance the antigen-induced production of immunoglobulin G1 antibodies.
Li X; Wang Y; Urso D; O'Rourke J; Cone RE
Immunology; 2004 Sep; 113(1):44-56. PubMed ID: 15312135
[TBL] [Abstract][Full Text] [Related]
39. Two different regulatory T cell populations that promote corneal allograft survival.
Cunnusamy K; Paunicka K; Reyes N; Yang W; Chen PW; Niederkorn JY
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6566-74. PubMed ID: 20702818
[TBL] [Abstract][Full Text] [Related]
40. High-dose cyclophosphamide inhibits anterior chamber-associated immune deviation (ACAID) and the production of extracellular antigen-specific T cell proteins induced by trinitrophenylated (TNP) spleen cells.
Wang Y; O'Rourke J; Cone RE
Cell Immunol; 1995 Oct; 165(2):284-8. PubMed ID: 7553893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]